c-Myc

c-Myc Overview

English NameMyc proto-oncogene proteinApproved Drugs0
Drugs in Clinical Trials10Target SynonymClass E Basic Helix-Loop-Helix Protein 39,Transcription Factor P64,Proto-Oncogene C-Myc,Myc-Related Translation/Localization Regulatory Factor,Avian Myelocytomatosis Viral Oncogene Homolog,V-Myc Myelocytomatosis Viral Oncogene Homolog,Myc Proto-Oncogene Protein,BHLHE39,C-Myc,MRTL,MYCC,Proto-Oncogene Proteins c-myc,MYC,MYC Proto-Oncogene, BHLH Transcription Factor,V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
Highest Development StagePhase 2 Clinical
English NameMyc proto-oncogene protein
Target SynonymClass E Basic Helix-Loop-Helix Protein 39,Transcription Factor P64,Proto-Oncogene C-Myc,Myc-Related Translation/Localization Regulatory Factor,Avian Myelocytomatosis Viral Oncogene Homolog,V-Myc Myelocytomatosis Viral Oncogene Homolog,Myc Proto-Oncogene Protein,BHLHE39,C-Myc,MRTL,MYCC,Proto-Oncogene Proteins c-myc,MYC,MYC Proto-Oncogene, BHLH Transcription Factor,V-Myc Avian Myelocytomatosis Viral Oncogene Homolog
Approved Drugs0
Drugs in Clinical Trials10
Highest Development StagePhase 2 Clinical

c-Myc Product List

  • Product Category

    Antibody (1)

  • Product Status

    Launched (1)

  • Species

    Mouse (1)

  • Tag

    - (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
MYC-MMYCc
Mouse
HEK293
Anti c-Myc Tag Monoclonal Antibody (9E10)
Total: 1
  • 1

c-Myc Background

The c-Myc tag is a widely used epitope tag in molecular biology for protein expression and detection. Derived from the human c-Myc oncoprotein. This tag is typically fused to target proteins through genetic engineering, allowing researchers to identify, purify, or track the expressed proteins using specific monoclonal antibodies.

c-Myc Synonyms

c-Myc,MYC,MRTL,bHLHe39

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
XNW-34017XNW-34017; XNW34017Phase 2 ClinicalEvopoint Biosciences Co LtdNeoplasm Metastasis; Solid tumours
Details
Sepantronium BromideYM-155; YM155 monobromide; PC-002Phase 2 ClinicalAstellas Pharma IncBreast Neoplasms; Burkitt Lymphoma; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Lymphatic Diseases; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Prostatic Neoplasms; Solid tumours
Details
OMO-103OMO-103; OMO103Phase 2 ClinicalPeptomyc SLCarcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Osteosarcoma; Pancreatic Neoplasms; Solid tumours
Details
WP-1066WP-1066Phase 2 ClinicalMoleculin Biotech IncBrain metastases; Brain Neoplasms; Diffuse Intrinsic Pontine Glioma; Glioblastoma; Glioma; Medulloblastoma; Melanoma
Details
PLX-51107PLX-51107Phase 1 ClinicalPlexxikon IncGraft vs Host Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Solid tumours
Details
SACT-1SACT-1Phase 1 ClinicalAptorum Group LlcNeuroblastoma
Details
MyrtleciclibVS 2370; VS2-370Phase 1 ClinicalVichem ChemieHIV Infections; Neoplasms
Details
WBC100WBC100; WBC-100Phase 1 ClinicalHangzhou Weben Pharmaceutical Co LtdHematologic Neoplasms; Leukemia, Myeloid, Acute; Neoplasms; Solid tumours
Details
LuxeptinibCG026806; CG-806; CG’806; CG-026806Phase 1 ClinicalCrystalgenomics IncHematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes
Details
MisetionamideGP-2250Phase 1 ClinicalGeistlich PharmaPancreatic Neoplasms
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland